Alnylam Pharmaceuticals Forecast and Stock Analysis
Technical ALNY stock analysis for Friday June 14, 2019.
Alnylam Pharmaceuticals fell by -1.70% in the last day ( Friday, 14th Jun 2019 ) from $71.24 to $70.03 During day the stock fluctuated 2.58% from a day low at $69.77 to a day high of $71.57. The price has risen in 6 of the last 10 days and is up by 3.72% over the past 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -88 039 shares and in total 383 546 shares bought and sold for approximately $26.86 million.
- 30 day high of the ALNY stock price was $72.78 and low was $65.81.
- 90 day high was $96.08 and low was $65.81.
- 52 week high for the Alnylam Pharmaceuticals - $124.22 and low - $60.27.
Alnylam Pharmaceuticals lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -28.24% during the next 3 months and, with 90% probability hold a price between $41.17 and $53.43 at the end of this period.
There are few to none technical positive signals at the moment. Alnylam Pharmaceuticals holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $70.44 and $71.91. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Thursday June 13, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Relative Strength Index (RSI)
RSI14 is 55 and the stock is currently not being overbought or oversold
Support & Resistance
Alnylam Pharmaceuticals finds support from accumulated volume at $68.77.
This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $1.80 (2.58%) between high and low. For the last week, the stock has had a daily average volatility of 3.31%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
3.31 %Average volatility
Very Low Low Medium High Very High
Alnylam Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|ALNY $70.03 ($-1.21 -1.70%)|
ALNY is down $1.21 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ALNY based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ALNY analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us